Literature DB >> 18610745

COX-2 as possible target for the inhibition of PGE2 production by Rikko-san in activated macrophage.

Norio Horie1, Ken Hashimoto, Takao Kato, Tetsuo Shimoyama, Tadayoshi Kaneko, Kaoru Kusama, Hiroshi Sakagami.   

Abstract

We have previously reported that Rikko-san (RKS) inhibited the lipopolysaccharide (LPS)-stimulated prostaglandin (PG) E2 in mouse macrophage-like RAW264.7 cells without affecting the expression of cyclooxygenase (COX)-2. Here RKS inhibition of the enzyme activity of both COX-1 and COX-2 proteins was investigated. Western blot analysis showed that RKS did not significantly change the S-nitrosylated COX-2 protein level. On the other hand, RKS inhibited the PG production catalyzed by purified COX-2, more effectively than that catalyzed by purified COX-1. These results suggest that RKS inhibits the PGE2 production by selectively inhibiting the COX-2 activity in activated macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18610745

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

Review 1.  Traditional Japanese herbal medicines for treatment of odontopathy.

Authors:  Kojiro Yamaguchi
Journal:  Front Pharmacol       Date:  2015-08-28       Impact factor: 5.810

2.  Studies on Shokyo, Kanzo, and Keihi in Kakkonto Medicine on Prostaglandin E2 Production in Lipopolysaccharide-Treated Human Gingival Fibroblasts.

Authors:  Toshiaki Ara; Norio Sogawa
Journal:  Int Sch Res Notices       Date:  2016-10-13

3.  Efficacy of rikkosan for primary burning mouth syndrome: a retrospective study.

Authors:  Hiroyuki Hato; Ken-Ichiro Sakata; Jun Sato; Takuya Asaka; Noritaka Ohga; Yutaka Yamazaki; Yoshimasa Kitagawa
Journal:  Biopsychosoc Med       Date:  2021-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.